No, there is no trouble in research. A few years back a senior manager in neurology was accused of retaliation against an Asian scientist who previously reported a compliance violation against said senior manager to HR. The Asian scientist was subsequently RIFed thus beginning a litany of lawsuits including this one. I believe Amgen responded appropriately by dismissing the senior manger and settling with the Asian scientist.
what neuroscience at Amgen? IF you are referring to the group of people that read the literature and copy what others are doing by making "drugs" (also known as antibodies which are made by nature), then what you are talking about is the Brain Innovation Group -Developing Innovative Cognitive Countermeasures. The Amgen abbreviation for them is the BIG-DICCs. Headed by the biggest of them all.
The senior manager was not "dismissed". In its infinite wisdom, HR transferred the senior manager to AFP, go figure. Watch your backs people, I'm watching mine.
